# Evaluation of ATx201 as a Topical Antibiotic Agent

> **NCT03009734** · PHASE1,PHASE2 · COMPLETED · sponsor: **UNION therapeutics** · enrollment: 73 (actual)

## Conditions studied

- Infection, Bacterial

## Interventions

- **DRUG:** ATx201 dermal formulations 2%

## Key facts

- **NCT ID:** NCT03009734
- **Lead sponsor:** UNION therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2018-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009734, "Evaluation of ATx201 as a Topical Antibiotic Agent". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03009734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*